Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GlycoQuest: Glycemic and Psychosocial Outcomes of a CGM-Integrated, AI-Adaptive Serious Game Digital Therapeutic in Newly Diagnosed Pediatric Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial

NCT07726680 is registered in ClinicalTrials.gov with Shifa International Hospital as lead sponsor.

NCT NCT07726680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07726680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GlycoQuest: Glycemic and Psychosocial Outcomes of a CGM-Integrated, AI-Adaptive Serious Game Digital Therapeutic in Newly Diagnosed Pediatric Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial
Lead sponsor
Shifa International Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
November 30, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes distress, family conflict, hypoglycemia (diabetic), type 1 diabetes mellitus (t1dm)